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tests (ETTs).Background The utility of additional diagnostic testing after ETT is not well characterized.Methods We followed consecutive individuals without known coronary artery disease referred for clinical ETT at a large
medical center. We measured the frequency and results of downstream imaging tests and invasive angiography
within 6 months of ETT and the combined endpoint of survival free from cardiovascular death, myocardial infarction,
and coronary revascularization.Results Among 3,656 consecutive subjects who were followed for a mean of 2.5  1.1 years, 332 (9.0%) underwent
noninvasive imaging and 84 (2.3%) were referred directly to invasive angiography after ETT. The combined endpoint
occurred in 76 (2.2%) patients. The annual incidence of the combined endpoint after negative, inconclusive, and
positive ETT was 0.2%, 1.3%, and 12.4%, respectively (p < 0.001). Rapid recovery of electrocardiography (ECG)
changes during ETT was associated with negative downstream test results and excellent prognosis, whereas typical
angina despite negative ECG was associated with positive downstream tests and adverse prognosis (p < 0.001).
Younger age, female sex, higher metabolic equivalents of task achieved, and rapid recovery of ECG changes were
predictors of negative downstream tests.Conclusions Among patients referred for additional testing after ETT, the lowest yield was observed among individuals with rapid
recovery of ECG changes or negative ETT, whereas the highest yield was observed among those with typical angina
despite negative ECG or a positive ETT. These ﬁndings may be used to identify patients who are most and least likely
to beneﬁt from additional testing. (J Am Coll Cardiol 2014;63:1264–74) ª 2014 by the American College of
Cardiology FoundationCoronary artery disease (CAD) remains the leading cause of
death in men and women. Although advances in cardiovas-
cular imaging have greatly improved our ability to diagnose
and treat CAD, the rising costs of noninvasive testing have
generated concern regarding its potential overuse (1).
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2013; revised manuscript received October 30,treadmill tests (ETTs) in the initial evaluation for ischemic
heart disease in patients who are able to exercise and have a
normal electrocardiogram (ECG) at baseline (2,3). In addi-
tion to testing for ischemic ECG changes, this test provides
other data that have important prognostic implications, such
as functional capacity, arrhythmias, and exercise-induced
symptoms (4).See page 1275Thus, a common and economically-appealing strategy is to
perform ETT as an initial test and then, among patients with
positive or inconclusive results, to selectively use noninvasive
imaging or invasive angiography to guide further care (5).
Although recent studies assessed patterns of downstream
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1265testing after percutaneous coronary intervention (PCI) (6,7)
and use of invasive angiography after stress testing (8), to
our knowledge, no data exist on the incidence and results of
downstream noninvasive testing after ETT in patients
without known CAD.
Therefore, the aim of our study was to identify the fre-
quency and results of downstream testing after ETT and
to identify predictors of patients who are most and least
likely to beneﬁt from additional testing.ETT = exercise treadmill test
METs = metabolic
equivalents of task
MI = myocardial infarction
MPHR = maximum predicted
heart rate
MRI = magnetic resonance
imaging
PCI = percutaneous coronary
intervention
SPECT = single-photon
emission computed
tomographyMethods
Population. The study population consisted of all consec-
utive patients who underwent clinically-indicated ETT at
Brigham and Women’s Hospital between January 1, 2009,
and December 31, 2010. We excluded patients with known
CAD; prior coronary artery bypass grafting, PCI, or
myocardial infarction (MI); and nonclinical indications for
testing such as participation in a research protocol or post–
heart transplant evaluation. The Partners Institutional
Review Board approved this study.
Clinical information. Demographics, clinical history, medi-
cations, and indications for testing were collected prospec-
tively through the use of a standardized patient interview. The
electronic medical record, which includes all physicians’ notes,
was used to identify the presence or absence of the following
risk factors: hypertension, diabetes, hyperlipidemia, and family
history of CAD. We estimated pre-test probability of CAD
by use of the Morise score (9).
Exercise treadmill testing. ETTs were performed with the
use of a symptom-limiting Bruce protocol according to
established guidelines (2) as part of routine clinical care. The
target heart rate was determined as 85% of the maximum
predicted heart rate (MPHR) (MPHR ¼ 220  age). All
ST-segment measurements were performed 80 ms after the J
point. The Duke Treadmill Score (DTS) was calculated for
each patient who completed the Bruce protocol as: exercise
time (min) – (5  maximal ST-segment depression [mm]) –
(4 angina index [0, no angina; 1, angina; 2, angina as reason
for stopping test]) (10).
We categorized each test result as positive, negative, or
inconclusive through the use of conventional criteria (2).
Positive tests were deﬁned as upsloping ST-segment
depressions 1.5 mm or downsloping or horizontal
depressions 1.0 mm in at least 2 leads. Inconclusive tests
were deﬁned to include any result that may be interpreted as
indeterminate and comprised the following categories: 1)
negative ECG with reduced sensitivity as the result of sub-
maximal exercise (<85% MPHR and rate-pressure pro-
duct <25,000); 2) positive ECG with reduced speciﬁcity as
the result of baseline ECG abnormalities; 3) positive ECG
with reduced speciﬁcity as the result of rapid recovery of ECG
changes, deﬁned as changes that resolve within 60 s; 4) typical
angina; 5) inappropriate dyspnea despite negative ECG
ﬁndings, and 6) clinically signiﬁcant rhythmdisturbances (any
sustained arrhythmia or >3 beats of ventricular tachycardia).Typical angina was deﬁned as
exertional chest discomfort that
was substernal and was relieved
with rest or nitroglycerin.
Downstream testing. For each
patient, we identiﬁed the use of
all noninvasive imaging and in-
vasive angiography tests perfor-
med within 6 months after ETT
through review of the electronic
medical record. The decision to
undergo further testing was at the
discretion of the referring physi-
cian. We chose the 6-month cut-
off to capture any downstream
testing thatwas probably triggered
by the ETT results.
Noninvasive imaging. We in-
cluded all possible subsequent
noninvasive imaging tests avail-
able at our institution: nuclear
stress tests, stress echocardiograms,
coronary computed tomography angiography (CCTA), and
stress magnetic resonance imaging (MRI). All tests were per-
formed and reported according to institutional protocols.
We categorized all nuclear stress tests (positron emission
tomography and single-photon emission computed tomog-
raphy [SPECT]) results as follows: negative (summed stress
score 2); inconclusive (equivocal scan results or negative
perfusion imaging with submaximal heart rate response
[<85% of MPHR]); and positive for “abnormal” or “prob-
ably abnormal” results (11).
We categorized CCTA results as negative for reports of
no plaque or stenosis 50% and positive for stenosis >70%
(or >50% in the left main coronary). We deﬁned as
inconclusive for the evaluation of ischemia any studies that
were uninterpretable or had moderate (51% to 70%) ste-
nosis, given that such lesions may not be associated with
ischemia and have uncertain hemodynamic signiﬁcance (12).
We categorized cardiac MRI results as negative if no
ischemia was detected, inconclusive if image quality pre-
cluded interpretation, and positive if ischemia was identiﬁed.
We categorized results of echocardiograms as positive,
negative, or inconclusive on the basis of the presence or
absence of stress-induced wall motion abnormalities. Tests
were deﬁned as inconclusive when reduced image quality
limited the evaluation or if patients failed to achieve 85% of
the MPHR.
Invasive coronary angiography. We deﬁned obstructive
CAD as a stenosis 50% in the left main coronary artery
or 70% in any other coronary vessel (13).
Patient follow-up for nonfatal MI and revascularization.
We reviewed all patient charts to identify incident nonfatal
MI and coronary revascularization, which comprised all PCI
and coronary artery bypass grafting procedures. MI was
deﬁned by means of universal criteria (14).
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determined patients’ vital status through the use of the
Social Security Death Index and the cause of death through
the use of chart review, autopsy ﬁndings, and hospice notes
where available. If the chart lacked information to deter-
mine the cause of death, we used death certiﬁcates obtained
from the Massachusetts Registry of Vital Records and
Statistics. Two cardiologists blinded to ETT results adju-
dicated the cause of death for each patient. Deaths were
considered to be of cardiovascular origin if the primary
cause was acute MI, atherosclerotic coronary vascular dis-
ease, congestive heart failure, valvular heart disease,
arrhythmic heart disease, stroke, or sudden and unknown
(15). Major adverse cardiovascular events were the com-
bined endpoint of cardiovascular death, nonfatal MI, and
coronary revascularization.
Statistical analysis. Continuous variables are expressed as
mean  SD or median and interquartile range, as appro-
priate. Categorical variables are presented as frequencies.
Differences between groups were tested with the use of
chi-square or Fisher exact tests for discrete variables and
1-way analysis of variance for continuous variables.
We constructed Kaplan-Meier curves to illustrate survival
free from cardiovascular events and tested for differencesTable 1 Baseline Characteristics Stratiﬁed by ETT
All
(n ¼ 3,656)
Negative
(n ¼ 2,4
Male 1,681 (46.0) 1,141 (4
Age, yrs 53  13 52  1
Hypertension 1,681 (46.0) 1,015 (4
Diabetes 470 (12.9) 287 (1
Hyperlipidemia 1,537 (42.0) 975 (3
Current smoker 468 (12.8) 267 (1
Family history of CAD 1,633 (44.7) 1,096 (4
BMI, kg/m2 28  6 28 
Morise score 10.4  4.5 9.8  4
Morise pre-test probability of CAD 35% 32%
Asymptomatic* 214 (5.9) 143 (6
Nonanginal chest pain 1,676 (45.8) 1,207 (4
Atypical chest pain 297 (8.1) 200 (8
Typical chest pain 241 (6.6) 113 (5
Dyspnea only 345 (9.4) 206 (8
Arrhythmia or palpitations only 440 (12.0) 315 (1
Other or unknown symptoms 443 (12.1) 294 (1
Lipid-lowering therapy 1,045 (28.6) 627 (2
Aspirin 1,103 (30.2) 669 (2
Beta-blocker 746 (20.4) 300 (1
METs 11  4 12 
Duke Treadmill Score 9  5 10 
No symptoms during test 2,420 (66.2) 1,831 (7
Typical angina during test 147 (4.0) 0
Atypical angina during test 185 (5.0) 119 (5
Dyspnea during test 459 (12.6) 193 (8
Other symptoms during test 445 (12.2) 335 (1
Values are n (%) or mean  SD. *Asymptomatic individuals also included exam
and exercise prescription.
BMI ¼ body mass index; CAD ¼ coronary artery disease; ETT ¼ exercise trebetween subgroups with the use of the log-rank test. We
built multivariable Cox proportional hazards models adjusted
for age and sex. The assumption of non–proportional hazards
was tested with the use of Schoenfeld residuals and resulted
in nonsigniﬁcant ﬁndings in all analyses. We performed a
sensitivity analysis that excluded all patients without com-
plete follow-up for all cardiovascular events.
To identify individuals in whom further testing may not be
necessary, we built multivariable logistic regression models
identifying predictors of negative downstream testing and
event-free survival. Our model was based on the assumption
that changes in patient treatment occur on the basis of the
identiﬁcation of disease; therefore, patients with negative test
results who had event-free survival did not beneﬁt from
testing. Our models used all of the clinical knowledge that
physicians might have at hand when deciding whether or not
to perform additional testing. Candidate predictor variables
were selected among relevant clinical variables because such
an approach with the use of external clinical judgment has
been shown to be superior to a p value–driven method (16).
Model variables included age, sex, risk factors, symptoms,
metabolic equivalents of task (METs) achieved, and ETT
results. The ﬁrst model included age, sex, risk factors, and
presenting symptoms. The second model added the ETTResults
ETT
78)
Inconclusive ETT
(n ¼ 1,043)
Positive ETT
(n ¼ 135) p Value
6.0) 471 (45.2) 69 (51.1) 0.423
3 57  12 61  11 <0.001
1.0) 588 (56.4) 78 (57.8) <0.001
1.6) 162 (15.5) 21 (15.6) 0.004
9.3) 494 (47.4) 68 (50.4) <0.001
0.8) 181 (17.4) 20 (14.8) <0.001
4.2) 470 (45.1) 67 (49.6) 0.449
6 29  7 28  6 <0.001
.5 11.6  4.3 12.6  4.2 0.059
40% 46% <0.001
.0) 66 (6.0) 5 (4.0) 0.202
8.7) 418 (40.1) 51 (37.8) <0.001
.1) 80 (8.0) 17 (13.0) <0.001
.0) 111 (11.0) 17 (13.0) <0.001
.3) 126 (12.0) 13 (10.0) <0.001
2.7) 116 (11.1) 9 (7.0) <0.001
1.9) 126 (12.0) 23 (17.0) <0.001
5.3) 366 (35.1) 52 (39.0) <0.001
7.0) 376 (36.0) 58 (43.0) <0.001
2.1) 405 (38.8) 41 (30.0) <0.001
4 9  3 10  3 <0.001
4 6  6 0.33  5 <0.001
3.9) 524 (50.2) 65 (48.0) <0.001
113 (11.0) 34 (25.0) <0.001
.0) 62 (6.0) 4 (3.0) 0.182
.0) 238 (22.8) 28 (21.0) <0.001
3.5) 106 (10.0) 4 (3.0) <0.001
inations performed for pre-operative evaluation, pre-transplant evaluation,
admill test; METs ¼ metabolic equivalents of task.
Figure 1 Exercise Treadmill Test Results
Frequency of inconclusive exercise treadmill test (ETT) results (N ¼ 1,043).
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1267results to the ﬁrst model. All tests were 2-sided, and a value of
p < 0.05 was considered statistically signiﬁcant. Statistical
analysis was performed with the use of Stata version 12.0
(Statacorp, College Station, Texas).
Results
Studypopulation. Among 4,262 consecutive patients referred
for ETT, we excluded 509 patients with prior diagnoses of
CAD, 9 patients age <18 years, and 88 patients with
indications other than CAD evaluation. The ﬁnal study
population included 3,656 patients, and 3,270 (90%) of
these patients had complete follow-up for all clinical
events.Table 2 Yield of Downstream Testing After ETT
All
(n ¼ 416 [11.4])
Nuclear MPI 270 (64.9%)
Normal 233 (86%)
Inconclusive 11 (4%)
Abnormal 26 (10%)
Stress echocardiogram 39 (9%)
Normal 32 (82%)
Inconclusive* 6 (15%)
Abnormal 1 (3%)
Coronary CTA 17 (4%)
No plaque or stenosis <50% 13 (76%)
Inconclusive
Uninterpretable 1 (6%)
Stenosis 50% to70% 1 (6%)
Stenosis >70% 2 (12%)
Stress MRI (all negative) 6 (1%)
Invasive angiography 84 (20%)
No obstructive CAD, no
revascularization
43 (51%)
Obstructive CAD, no revascularization 4 (5%)
PCI 24 (29%)
CABG 13 (15%)
Values are n (%). *All inconclusive stress echocardiogram results were due
CABG ¼ coronary artery bypass grafting; CTA ¼ computed tomography
resonance imaging; PCI ¼ percutaneous coronary intervention; other abbrevCompared with those with complete follow-up, patients
with incomplete follow-up achieved higher METs, had a
higher DTS, and were less likely to have typical angina
symptoms (p < 0.001 for all comparisons). Patients with
incomplete follow-up for downstream clinical events (who
still had complete information on downstream testing) also
had a lower rate of downstream testing (6.5% vs. 11.9%,
p ¼ 0.001). Additionally, 100% follow-up for all-cause
mortality was available. When evaluating for differences
between those with complete versus incomplete follow-up for
cardiovascular outcomes, we found a similar annual incidence
of all-cause mortality (0.53% vs. 0.49%; p ¼ 0.95).
A sensitivity analysis excluding all patients with incom-
plete follow-up had similar results (Online Appendix 1A).
Baseline characteristics. The baseline characteristics of the
patient population (age 54  13 years; 46.0% men) stratiﬁed
by ETT examination results are presented in Table 1.
As expected, patients with positive and inconclusive
ETT results were older and had a higher frequency of risk
factors.
The ETTs were negative for ischemia in 2,478 (67.7%),
inconclusive in 1,043 (28.5%), and positive for ischemia in
135 (3.7%) patients. The most common types of inconclu-
sive results were submaximal exercise (56.7%), followed by
rapid recovery of ECG changes (12.9%) and typical an-
gina despite no ECG changes (9.9%) (Fig. 1). Among
318 patients with ST-segment depressions, 314 (98.7%)
had horizontal or downsloping ST-segment depressions
1.0 mm, whereas 4 (1.3%) had upsloping ST-segmentNegative ETT
(n ¼ 63 [3])
Inconclusive ETT
(n ¼ 260 [24.9])
Positive ETT
(n ¼ 94 [70])
40 (63%) 184 (71%) 47 (50%)
37 (93%) 159 (86%) 37 (79%)
1 (3%) 9 (5%) 1 (2%)
1 (3%) 16 (9%) 9 (19%)
10 (16%) 25 (10%) 4 (4%)
10 (100%) 18 (72%) 4 (100%)
0 6 (24%) 0
0 1 (4%) 0
3 (5%) 12 (5%) 2 (2%)
2 (67%) 11 (92%) 0
0 0 1 (50%)
0 0 1 (50%)
1 (33%) 1 (8%) 0
1 (2%) 5 (2%) 0
9 (14%) 34 (13%) 41 (44%)
7 (78%) 19 (56%) 17 (41%)
0 3 (9%) 1 (2%)
1 (11%) 12 (35%) 11 (28%)
1 (11%) 0 12 (29%)
to submaximal exercise.
angiography; MPI ¼ myocardial perfusion imaging; MRI ¼ magnetic
iations as in Table 1.
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1268depressions 1.5 mm. For patients with rapid recovery of
ECG changes, the median time to resolution of ST-segment
changes was 32 s (interquartile range: 27 to 60 s).
Downstream testing. Further testing was undertaken in
416 (11.4%) subjects within 6 months of ETT: 332 (9.1%)
underwent noninvasive imaging and 84 (2.3%) were referred
directly to invasive angiography.
When evaluating the rate of all downstream testing by
ETT results, 63 (3%) individuals with negative ETT results,
260 (24.9%) individuals with inconclusive ETT results, and
94 (70%) individuals with positive ETT results underwent
further testing. Notably, the 260 patients with inconclusive
ETT accounted for the highest proportion (62.4%) of
downstream tests. Within this group, 81 (60%) of 134
patients with rapid recovery of ECG changes underwent
downstream testing compared with 41 (40%) of 103 patients
with typical angina despite negative ECG results.
Among patients referred for subsequent imaging, 270
(81.3%) underwent nuclear stress tests, 39 (12%) underwentFigure 2 Results of Downstream Testing
Results of noninvasive imaging (A), invasive angiography (B), and all imaging (C) obtained
ranges from 0% to 21%, being lowest after rapid recovery of ECG changes and highest after
A and B are combined. Obstructive disease denotes stenosis 50% in the left main coron
obstructive disease or coronary revascularization within 6 months after the most recent tes
Figure 1.stress echocardiograms, 17 (5%) underwent CCTA, and
6 (2%) underwent cardiac MRI. Because only 12 patients
(0.3%) received more than 1 noninvasive imaging test within
6 months of ETT 6 nuclear stress tests followed by CCTA,
1 nuclear stress tests followed by MRI, 5 nuclear stress tests
followed by stress echocardiology), only the ﬁrst test after
ETT was included in the present analysis. Overall, exercise
stress testing was performed in 233 of 315 (73.9%) imaging
stress tests. However, among those who did not achieve
adequate heart rate response on the initial ETT, the majority
(46 of 59, 78%) underwent pharmacological stress testing
with SPECT or stress echocardiography. Among the 12
patients who were referred for exercise testing with SPECT
after a submaximal ETT, 8 (67%) received regadenoson at
peak stress to induce maximal hyperemia and improve the
diagnostic accuracy of the examination (17).
The results of all downstream tests are summarized in
Table 2. Among the 26 patients with positive nuclear tests,
1 patient had a ﬁxed defect, whereas all others had ischemia.within 6 months after ETT stratiﬁed by test results. The rate of positive results (yield)
typical angina despite negative ECG results or a positive ETT result. (C) Results from
ary or 70% in all other coronary vessels. Positive angiography results denote either
t. Negative angiography denotes absence of obstructive disease. Abbreviations as in
Figure 3
Results of Invasive Angiography in Patients Who
Underwent Imaging After Exercise Treadmill Testing
All invasive angiography studies that occurred within 6 months after imaging are
shown. The yield of invasive angiography was higher after positive imaging (56%)
than after negative imaging (25%). Obstructive disease denotes stenosis 50% in
the left main coronary or 70% in all other coronary vessels.
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noninvasive imaging tests varied from 0% to 21% (Fig. 2A).
The lowest yield was observed among tests that demon-
strated rapid recovery of ECG changes: none of the 77
imaging tests were positive. Notably, this was similar to the
yield observed after negative ETT (2 of 53, 4%). On the other
hand, the highest yield (21%) was observed among tests that
demonstrated typical angina despite no ECG changes: 7 of
33 were positive. This was similar to the positive imaging rate
after positive ETT (11 of 53, 21%). Similar results were
obtained when the analysis of yield of downstream testing
was restricted to patients undergoing nuclear stress testing
(Online Appendix 1B).
Among patients with typical angina but no ECG changes
who were referred directly to invasive angiography after
ETT, all 8 (100%) underwent coronary revascularization.
Among those referred with rapid recovery of ECG changes,
2 of 4 (50%) patients underwent coronary revascularization
(Fig. 2B).
A yield similar to that of noninvasive imaging was
observed when the results of both noninvasive and invasive
imaging were combined (Fig. 2C). The rates of positive
downstream testing after negative, inconclusive, and positive
ETT were 8%, 14%, and 39%, respectively. Whereas the
overall number of patients with high-risk DTS (–11) was
low, when we examined the yield of downstream testing in
those with a low-risk (5) versus intermediate-risk DTS
(between –10 and 4), there was no signiﬁcant difference (p¼
0.268). In a comparison of patients with positive versus
negative downstream tests, a higher proportion of patients
with positive downstream tests were male, older, and had a
lower DTS and typical angina during ETT (Online
Appendix 1C).
Among patients with typical angina and no ECG changes,
those with positive downstream tests were more likely to be
male (79% vs. 37%; p ¼ 0.012) and older (62 years vs. 53
years; p ¼ 0.049) than those with negative or equivocal
downstream tests; however, METs achieved and DTS were
not signiﬁcantly different between these groups. Among the
7 patients who had positive imaging tests after ETTs with
typical angina but no ST depressions, 1 had severe stenosis
(>70%) on CCTA. Among the 6 patients who had positive
nuclear imaging, 3 patients had mild ischemia (summed
difference score <4), 1 patient had moderate ischemia
(summed difference score 4 to 7), and 2 patients had severe
ischemia (summed difference scores 8). One patient who
had severe ischemia also had transient ischemic dilation of
the left ventricle as well as a decrease in ejection fraction
from rest to stress on positron emission tomography imag-
ing. Among patients with negative downstream testing in
this group (n ¼ 25), there were no high-risk features such as
transient ischemic dilation of the left ventricle or a decrease
in ejection fraction from rest to peak stress.
Figure 3 depicts the yield of invasive angiography after
imaging tests that followed ETT. Subsequent revasculari-
zation was performed in 10 of 17 (59%) of patients withpositive imaging and 2 of 8 (25%) patients with negative
imaging.
Outcomes. During the 8,282 person-years of follow-up
(median 2.7 years; interquartile range: 2.1 to 3.3 years),
47 (1.3%) patients died: 9 (0.25%) as the result of cardio-
vascular causes, 11 (0.3%) patients had MI, and 69 (2%)
patients required coronary revascularization. Overall, 76
(2.2%) patients had the combined endpoint of major
adverse cardiovascular events. The annual incidence of the
combined endpoint after negative, inconclusive, and posi-
tive ETT was 0.2%, 1.3%, and 12.4%, respectively (p <
0.001). Among patients with rapid recovery of ECG
changes, the annual incidence was 0.7%, whereas among
those with typical angina but negative ECG the incidence
was 7.4%.
Figure 4 shows unadjusted Kaplan-Meier cumulative
event curves for nonfatal MI or cardiovascular death
(Fig. 4A) and nonfatal MI, revascularization, or cardiovas-
cular death (Figs. 4B and 4C) according to ETT results.
Patients with inconclusive ETTs had a lower rate of survival
free from cardiovascular death or MI than those with a
negative ETT (p < 0.001) (Fig. 4A). When speciﬁcally
examining patients with inconclusive ETTs, rapid recovery
of ECG changes was associated with favorable prognosis,
whereas typical angina despite negative ECG ﬁndings was
associated with adverse prognosis (Fig. 4C). When further
stratifying the most common inconclusive groups by func-
tional capacity, a higher exercise capacity was associated with
a better prognosis only for the group with submaximal ex-
ercise (p ¼ 0.013) (Fig. 5).
Individuals less likely to beneﬁt from additional testing.
Table 3 shows the results of multivariable models predicting
negative downstream tests and no downstream events after
Figure 4 Kaplan-Meier Curves Examining Outcomes According to Exercise Treadmill Testing Results
(A) Survival free from myocardial infarction (MI) or cardiovascular death (CVD). Rates of MI or CVD were higher among patients with inconclusive exercise treadmill test (ETT)
(hazard ratio [HR]: 5.4; p ¼ 0.004) and positive ETT (HR: 8.6; p ¼ 0.006) than among those with negative ETT results. (B and C) Survival free from the combined endpoint of MI,
CVD, or coronary revascularization. Rates of the combined endpoint were higher among patients with inconclusive ETT results (HR: 5.1; p < 0.001) and positive ETT results
(HR: 36.1; p < 0.001). Patients with typical angina despite negative ECG had a higher incidence of the combined endpoint than other types of inconclusive ETT. *HRs were
derived from Cox proportional hazards models adjusted for age and sex.
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1270ETT. Younger age (p < 0.001), female sex (p < 0.001),
higher METs (p ¼ 0.037), and rapid recovery of ECG
changes (p ¼ 0.013) were independent predictors of negative
downstream tests and event-free survival.
Discussion
In the present study, we examined patterns of downstream
testing and outcomes in a cohort of 3,656 patients with-
out prior CAD referred for ETT. Although we found
an overall low rate of referral for downstream testing
(11%)dconsistent with the high prevalence of negative
ETT resultsdthere was a substantially higher rate of referral
for additional testing among patients with positive (70%) or
inconclusive (25%) test results. Moreover, we found that
28% of the patients in our study had inconclusive ETT
results; despite a favorable prognosis, this group accountedfor 63% of all the downstream tests. In our analysis of
inconclusive results, we identiﬁed that patients who had
rapid recovery of ECG changes had an excellent prognosis
and a low yield of additional testing, whereas patients who
had typical angina despite negative ECG results had a worse
prognosis and higher yield of downstream testing.
An important ﬁnding of our study is that patients with
typical angina but negative ETT represent a relatively
higher-risk cohort in which the yield of additional testing is
relatively higher and comparable to the yield after positive
ETT. These results are particularly important in light of a
recent study by Cheng et al. (18), which suggested that
the prevalence of obstructive CAD by CCTA is vastly
overestimated in patients with typical angina. However, the
study by Cheng et al. (18) used patient-reported symptoms,
whereas, in our study, physicians and exercise physiologists
identiﬁed symptoms at the time of testing. Our results
Figure 5 Kaplan-Meier Curves
Kaplan-Meier curves describe survival free from the combined endpoint of MI, revascularization, or CVD for inconclusive ETTs stratiﬁed by functional capacity as measured by
metabolic equivalents of task (METs) achieved during ETT (4). Whereas there are no differences in event-free survival by functional capacity in the inconclusive ETT and typical
angina groups, among patients with submaximal exercise, patients who achieved 7 METs had a lower event rate (p ¼ 0.013, log-rank test). Abbreviations as in Figure 4.
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1271suggest that patients who have development of typical angina
during ETT, even in the presence of a good exercise capacity,
warrant further evaluation. Bairey et al. (19) showed that
among 190 patients with typical angina but negative ETT,
an abnormal thallium myocardial perfusion study was found
in 24% (similar to our ﬁndings) and that such testing pro-
vided signiﬁcant prognostic value.
Another noteworthy ﬁnding from our study is that patients
with rapid recovery of ECG changes had a low yield on
subsequent imaging and few adverse outcomes. Although it is
recognized that ST-segment depressions that resolve rapidly
have a lower speciﬁcity for detecting obstructive CAD (20),
to our knowledge, no prior studies have investigated the yield
of imaging and prognosis of such patients. In our study,
81 (60%) of the 134 patients who had positive ECG changes
with rapid recovery underwent downstream testing. Among
the 77 patients referred for noninvasive imaging, there were
no positive results and no subsequent deaths or MIs. Two
of 4 patients, who, per treating physician discretion, were
referred directly to coronary angiography underwent coronaryrevascularization procedures. One of these patients achieved
10.1 METs and had typical angina with 2.0-mm horizontal
ST-segment depressions in leads V3 to V6 that resolved
within 1 min into recovery, whereas the second patient ach-
ieved 7.8 METs and had dyspnea on exertion with 1.0-mm
horizontal ST-segment depressions in leads V5 to V6, which
resolved 30 s into recovery.
Given the concerns regarding overuse of imaging tests,
a key objective of our study was to identify individuals
who can safely avoid further testing after ETT. As is con-
sistent with established risk factors for obstructive CAD,
a younger age, female sex, and higher exercise capacity
during ETT were all independently associated with nega-
tive downstream testing and event-free survival. In addi-
tion, rapid recovery of ECG changes was independently
associated with negative downstream testing and event-free
survival.
Patel et al. (21) have demonstrated a low yield of iden-
tiﬁcation of obstructive CAD in noninvasive testing com-
pared with invasive angiography; however, their study
Table 3 Predictors of Negative Downstream Tests and No Events
Univariate Predictors p Value Multivariable Model 1 p Value Multivariable Model 2 p Value
Likelihood ratio chi-square d 61.49 <0.001 80.67 0.002*
ROC d 0.7149 d 0.7451 0.018*
AIC d 560.26 d 551.07 d
Age (per 10 yrs) 0.67 (0.56–0.78) <0.001 0.65 (0.54–0.78) <0.001 0.72 (0.60–0.88) 0.001
Female 2.69 (1.81–4.01) <0.001 2.89 (1.89–4.44) <0.001 3.17 (2.00–5.01) <0.001
1 risk factory 1.00 Reference 1.00 Reference 1.00 Reference
2 risk factorsy 0.66 (0.42–1.01) 0.0564 0.59 (0.37–0.95) 0.030 0.65 (0.40–1.06) 0.087
Presenting symptoms
None 1.00 Reference 1.00 Reference 1.00 Reference
Non anginal chest pain 1.16 (0.74–1.81) 0.527 0.83 (0.51–1.35) 0.442 0.89 (0.54–1.48) 0.656
Atypical angina 0.65 (0.33–1.28) 0.216 0.52 (0.25–1.07) 0.079 0.62 (0.29–1.31) 0.209
Typical angina 0.53 (0.29–0.94) 0.029 0.40 (0.21–0.76) 0.005 0.50 (0.25–1.01) 0.052
ETT results
METs achieved (per MET) 1.08 (1.03–1.15) 0.005 d d 1.09 (1.01–1.17) 0.037
Negative ETT 1.00 Reference d d 1.00 Reference
Typical angina, negative ECG 0.73 (0.35–1.52) 0.401 d d 0.95 (0.40–2.26) 0.911
Rapid recovery of ECG changes 3.64 (1.62–8.19) 0.002 d d 2.67 (1.15–6.22) 0.013
Inconclusive for other reasons 1.06 (0.62–1.81) 0.832 d d 1.32 (0.71–2.45) 0.380
Positive ETT 0.59 (0.33–1.06) 0.076 d d 0.64 (0.34–1.21) 0.173
Values are ﬁt statistic or odds ratio (95% conﬁdence interval). *Comparing models 1 and 2. yRisk factors included hypertension, diabetes, dyslipidemia, current smoking, and family history of premature
coronary artery disease.
AIC ¼ Akaike Information Criterion; ROC ¼ receiver-operating characteristic curve; other abbreviations as in Table 1.
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1272included several types of tests (including rest-only echocar-
diogram and ECG). In our study, among patients referred
for invasive angiography after a positive imaging study, the
yield was 59% (Fig. 3), higher than the 41% observed by
Patel et al. (21). However, it should be recognized that
discordant ﬁndings are not unexpected when tests that
evaluate ischemia are compared with an anatomical reference
standard (12).
Our ﬁndings are similar to those of Mudrick et al. (8),
who followed 80,676 patients who underwent stress testing
(54% nuclear; 25% ETT; 21% stress echocardiography):
within 60 days after testing, the incidence of invasive angi-
ography among ETT patients was 6.9%, whereas the inci-
dence of coronary revascularization was 2.3%. Interestingly,
these rates were higher than those observed in our study.
This could be explained by increased use of noninvasive
imaging in our population, although Mudrick et al. (8), who
used an administrative database, did not report data on the
use of noninvasive testing.
Consistent with prior studies (8), the rates of positive
ETT results and adverse events observed in our study were
low, in keeping with the fact that patients referred for ETT
alone are generally at lower risk that those who are referred
for noninvasive imaging. Furthermore, we excluded patients
with CAD. These results highlight the challenges of the
use of diagnostic testing to mitigate the risk of events in an
already low-risk population. For instance, approximately
40% of patients with a positive ETT result had a positive
downstream test, reﬂecting the low speciﬁcity of ECG
changes for predicting abnormal imaging or angiography.
Nevertheless, despite the overall low event rate of our
cohort, we were able to identify subgroups of patients (e.g.,typical angina) in which additional testing provided clini-
cally important data as well as subgroups (e.g., rapid re-
covery of ECG changes) in which excessive testing was
performed despite an event rate that was lower than
that observed among individuals who had negative ETT
testing.
When selecting an imaging test after equivocal ETT re-
sults, the reason for the inconclusive ETT results should be
considered. For instance, among patients who are unable to
achieve their target heart rate with exercise, future testing
should use pharmacological stress testing with either vaso-
dilators or dobutamine (22). In our study, some patients
were referred for exercise SPECT despite a suboptimal heart
rate response on ETT and were administered regadenoson
at peak exercise to induce maximal hyperemic response and
thus improve the diagnostic accuracy while reducing the
likelihood of inconclusive results (18).
Study limitations. Given the observational single-center
design of our study, our results may be less applicable to
other institutions. For instance, centers probably vary by
how they interpret and report ETT ﬁndings as well as which
testing options are available or used when further testing is
obtained. However, our primary aim was to identify the
frequency of downstream testing after ETT and to identify
predictors of patients who are most and least likely to beneﬁt
from additional testing. Although the pattern of down-
stream use of imaging modalities differs across centers, we
would not expect our ﬁndings to change even if different
modalities of downstream testing were obtained. Never-
theless, our center is well-suited for this study, given that:
1) ETT is commonly used as the ﬁrst test to evaluate pa-
tients with no CAD; and 2) we have an integrated multi
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that includes all patient characteristics as well as all nonin-
vasive and invasive testing performed. Although we assumed
that any testing within 6 months of the ETT examination
was attributable to the test results, it is possible that some
downstream testing occurred because of changes in clinical
status.
Certain assumptions are implied by our analysis. We
deﬁned a “beneﬁt” (e.g., yield) of a downstream test as a
positive result because we assumed that positive test results
are more likely to affect patient treatment. However, our
deﬁnition of yield might discount the value of reassurance
provided by negative test results. Moreover, because not all
patients in our cohort underwent secondary testing, referral
bias may inﬂuence the frequency of positive downstream test
results across some of the subgroups of patients referred for
invasive angiography or noninvasive testing. However, our
aim was to observe the yield in actual clinical practice
because such results may be more applicable to patients in
whom physicians are contemplating performing additional
testing.
We deﬁned inconclusive ETT results broadly to compare
different subgroups. As a result, the rate of inconclusive
studies may be higher than would be expected if a more
conservative deﬁnition were used. However, our rate of
inconclusive studies (28%) was similar to that reported by
others (3,23). Moreover, our ﬁndings regarding the yield and
prognosis associated with various ETT ﬁndings would not
be expected to change even if some of the inconclusive
subgroups listed in Figure 1 were reclassiﬁed as positive or
negative. Nevertheless, several of the subgroups of patients
with inconclusive ETT results were small, thus limiting our
power to detect differences in outcomes. Finally, our ﬁndings
at this time represent only medium-term follow-up, and it is
possible that longer-term follow-up would identify more
events.
Conclusions
To our knowledge, this is the ﬁrst study to assess down-
stream noninvasive testing after ETT among patients
without CAD. In recognition of the increased concerns
regarding overuse of cardiovascular imaging, it is essential to
develop effective patient-centered algorithms to identify the
best initial testing option for a given patient. Given the
overall good prognosis as well as low need for downstream
testing, our results suggest that ETT represents a reasonable
initial testing option for many patients without prior CAD
who are able to exercise and have a normal baseline ECG.
Furthermore, we identify that in the absence of any high-
risk features, patients with rapid recovery of ECG changes
do not beneﬁt from additional diagnostic testing. On the
other hand, we found that patients with typical angina have
an absolutely low but relatively higher yield of downstream
testing, which suggests that some of these patients might
warrant further evaluation and/or treatment. Our ﬁndingscould be used to reduce the number of inconclusive results
and downstream testing by more deﬁnitely reclassifying
ETT results as positive or negative. In establishing the
optimal threshold for any diagnostic test, there is a trade-off
between sensitivity and speciﬁcity. Our ﬁndings imply that
the potential gain in sensitivity is extremely small and is
probably unjustiﬁed for patients with rapid recovery of ECG
changes.
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For supplemental ﬁgures and a table, please see the online version of this
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